Amadix — Debt · €15M

The European Investment Bank signed a €15M venture loan with Amadix, backed by the InvestEU guarantee, to fund R&D, manufacturing and commercialisation of PreveCol plus the PancreaDix and DiagnoLung pipeline, and to support US clinical validation and European/US expansion. The EIB put the total cost of the underlying project at roughly €45M; the company had applied for the loan in the first half of 2024.